Physician Assistant · Chicago, IL
NPI
1770107195
Since 2020
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2701 W 68th St
Chicago, IL, 60629
Phone (773) 884-9000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,568
24 services
Medicare patients, 2024
21
Average age 75
Drug cost, 2024
$2.3M
464 prescriptions
Company payments, 2025
$1,357
From 18 companies
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Czarnowski prescribed most often to Medicare patients was Anastrozole, with 53 prescriptions and refills. In total Daniel Czarnowski wrote 464 Medicare prescriptions that cost $2.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 53 | 86 | 19 | $585 |
| Hydroxyurea Generic | 26 | 31 | Under 11 | $238 |
| Dexamethasone Generic | 26 | 26 | Under 11 | $351 |
| Pomalyst Pomalidomide | 25 | 25 | Under 11 | $578K |
| Rubraca Rucaparib Camsylate | 24 | 24 | Under 11 | $416K |
| Potassium Chloride Generic | 24 | 32 | 11 | $193 |
| Acyclovir Generic | 21 | 23 | Under 11 | $332 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 19 | 19 | Under 11 | $463 |
| Abiraterone Acetate Generic | 14 | 14 | Under 11 | $13K |
| Allopurinol Generic | 13 | 17 | Under 11 | $192 |
| Lenalidomide Generic | 13 | 13 | Under 11 | $201K |
| Xtandi Enzalutamide | 12 | 12 | Under 11 | $155K |
| Prednisone Generic | 11 | 11 | Under 11 | $61.31 |
Brand drugs: 139 claims; generic drugs: 325 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Czarnowski $1,357 ($1,357 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $373.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 16 | $373 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $104 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $101 |
| Array Biopharma Inc PFE | 5 | $96.66 |
| Fresenius Kabi USA, LLC | 5 | $95.6 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $86.74 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $84.79 |
| Daiichi Sankyo Inc. 4568.T | 3 | $78.83 |
| Merck Sharp & Dohme LLC MRK | 3 | $60.64 |
| Pfizer Inc. PFE | 2 | $54.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.